Ommoleila Molavi
- Molecular Biology top 5%
- Immunology top 5%
- Biomaterials top 2%
- Oncology top 5%
- Cancer Research top 5%
- Co-authors
- Afsaneh LavasanifarRaymond LaiJohn SamuelZengshuan MaAzita HaddadiSevda JafariMehdi SabzichiSamar Hamdy
- Topics
- Cytokine Signaling Pathways and Interactions (15 papers)Nanoparticle-Based Drug Delivery (12 papers)Immunotherapy and Immune Responses (12 papers)
- Journals
- SHILAP Revista de lepidopterologíaBloodBiomaterials
- Partner nations
- IranCanadaUnited States
In The Last Decade
Ommoleila Molavi
71 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Molecular Biology 1.3k
- Immunology 557
- Biomaterials 541
- Oncology 507
- Cancer Research 388
Countries citing papers authored by Ommoleila Molavi
This map shows the geographic impact of Ommoleila Molavi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ommoleila Molavi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ommoleila Molavi more than expected).
Fields of papers citing papers by Ommoleila Molavi
This network shows the impact of papers produced by Ommoleila Molavi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ommoleila Molavi. The network helps show where Ommoleila Molavi may publish in the future.
Co-authorship network of co-authors of Ommoleila Molavi
This figure shows the co-authorship network connecting the top 25 collaborators of Ommoleila Molavi. A scholar is included among the top collaborators of Ommoleila Molavi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ommoleila Molavi. Ommoleila Molavi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 7 | |
| 3 | 16 | |
| 4 | 9 | |
| 5 | 31 | |
| 6 | 38 | |
| 7 | 12 | |
| 8 | 16 | |
| 9 | 10 | |
| 10 | 12 | |
| 11 | Up-down regulation of HIF-1α in cancer progressionbreakdown → | 190 |
| 12 | 31 | |
| 13 | 18 | |
| 14 | 5 | |
| 15 | 20 | |
| 16 | 76 | |
| 17 | 16 | |
| 18 | 62 | |
| 19 | 202 | |
| 20 | 73 |
About Ommoleila Molavi
Ommoleila Molavi is a scholar working on Oncology, Molecular Medicine and Biomaterials, having authored 73 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (15 papers), Nanoparticle-Based Drug Delivery (12 papers) and Immunotherapy and Immune Responses (12 papers). The work is most often cited by research in Molecular Medicine (219 citations), Biomaterials (541 citations) and Pharmaceutical Science (192 citations). Ommoleila Molavi has collaborated with scholars based in Iran, Canada and United States. Frequent co-authors include Afsaneh Lavasanifar, Raymond Lai, John Samuel, Zengshuan Ma, Azita Haddadi, Sevda Jafari, Mehdi Sabzichi, Samar Hamdy, Mohammad Saeid Hejazi and Mohammad Reza Vakili. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.